文献速递肾小球疾病遗传性与小管间质肾病

一种新型纳米荧光素酶转基因报告系统测量斑马鱼蛋白尿

A novel nanoluciferase transgenic reporter measures proteinuria in zebrafish.
PubMed 文献 · Kidney Int · 2022-06-15

研究利用Tol2转座子系统构建了由fabp10a肝特异性启动子驱动表达NL-D3(纳米荧光素酶与受体相关蛋白D3结构域融合)的转基因斑马鱼品系,通过检测胚胎培养基中发光强度定量幼鱼蛋白尿。化学损伤近端小管重吸收或肾小球滤过以及敲低多个肾病相关基因均诱导NL-D3蛋白尿,卡托普利可减少col4a4敲低模型的蛋白尿。

要点

  • NL-D3转基因斑马鱼可通过发光计定量检测培养基中NL-D3来评估蛋白尿。
  • 化学损伤近端小管重吸收(顺铂、庆大霉素)或肾小球滤过(血管紧张素II、Hanks平衡盐溶液、牛血清白蛋白)均诱导NL-D3蛋白尿。
  • 敲低nphs1、nphs2、lrp2a、ocrl、col4a3和col4a4诱导NL-D3蛋白尿,卡托普利减少col4a4敲低模型的蛋白尿。

核心结论

  • NL-D3转基因斑马鱼可作为稳健且可定量的蛋白尿报告系统,鉴于斑马鱼高通量实验的可行性,该新型报告系统可用于筛选改善蛋白尿的药物,从而优先选择候选药物进行进一步转化研究。

研究设计与样本

  • 利用Tol2转座子系统构建转基因斑马鱼品系,由fabp10a肝特异性启动子过表达纳米荧光素酶与受体相关蛋白D3结构域融合的NL-D3。
  • 使用发光计检测胚胎培养基中发光强度,在NL-D3斑马鱼幼鱼中定量蛋白尿。

主要发现

  • 健康状态下NL-D3不被排泄,但胚胎经影响近端小管重吸收的化学物质(顺铂、庆大霉素)或影响肾小球滤过的物质(血管紧张素II、Hanks平衡盐溶液、牛血清白蛋白)处理后,可在鱼培养基中检测到NL-D3。
  • 敲低nphs1、nphs2、lrp2a、ocrl、col4a3和col4a4等肾病相关基因产物同样诱导NL-D3蛋白尿。
  • 在col4a4敲低的斑马鱼幼鱼(Alport综合征模型)中,卡托普利治疗减少了该系统中的蛋白尿。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The zebrafish is an important animal system for modeling human diseases. This includes kidney dysfunction as the embryonic kidney (pronephros) shares considerable molecular and morphological homology with the human nephron. A key clinical indicator of kidney disease is proteinuria, but a high-throughput readout of proteinuria in the zebrafish is currently lacking. To remedy this, we used the Tol2 transposon system to generate a transgenic zebrafish line that uses the fabp10a liver-specific promoter to over-express a nanoluciferase molecule fused with the D3 domain of Receptor-Associated Protein (a type of molecular chaperone) which we term NL-D3. Using a luminometer, we quantified proteinuria in NL-D3 zebrafish larvae by measuring the intensity of luminescence in the embryo medium. In the healthy state, NL-D3 is not excreted, but when embryos were treated with chemicals that affected either proximal tubular reabsorption (cisplatin, gentamicin) or glomerular filtration (angiotensin II, Hanks Balanced Salt Solution, Bovine Serum Albumin), NL-D3 is detected in fish medium. Similarly, depletion of several gene products associated with kidney disease (nphs1, nphs2, lrp2a, ocrl, col4a3, and col4a4) also induced NL-D3 proteinuria. Treating col4a4 depleted zebrafish larvae (a model of Alport syndrome) with captopril reduced proteinuria in this system. Thus, our findings validate the use of the NL-D3 transgenic zebrafish as a robust and quantifiable proteinuria reporter. Hence, given the feasibility of high-throughput assays in zebrafish, this novel reporter will permit screening for drugs that ameliorate proteinuria, thereby prioritizing candidates for further translational studies.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Naylor RW, Lemarie E, Jackson-Crawford A, et al. A novel nanoluciferase transgenic reporter measures proteinuria in zebrafish. Kidney Int. 2022. PMID: 35716957. doi:10.1016/j.kint.2022.05.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。